We have been requested to review and present to you our recommendations for the start of your new Pharmaceutical/Biotech Consulting Company. To begin, we would like to review the information that we have been given from you to KMCE&A. We understand that you have a background as a business executive as well as a scientific background. Your business plan states you are starting up a consulting company that will handle R&D monitoring for other companies that are in the Pharmaceutical/Biotech Industry. Your client base is mostly in the New Jersey and Pennsylvania area but hope to eventually expand to a global customer base. Your main investments will be in salaries in that as a services industry you will have minimal asset investments. Your personal preference is to have no personal liability. You would like to keep the ownership small and retain the majority ownership of 50% to 60% so that you can keep control of the decision making. However you are open to issuing stock if the funding of your business would benefit from this over financing through debt. You also expect to have a loss of approximately $25,000 in the first year due to start up costs and become profitable by year two. You initially will have three employees joining you at the start of the business. Two employees, Scott & Kate, will be contributing services of an IT specialist and a marketing/public relations as well as a program manager. The third member, Todd, who is an attorney, will not only contribute legal services but also an initial investment of $50,000. We also understand that you have $200,000 of personal funds to invest as well as have obtained an additional $500,000 in financing through securing your own personal assets.…